34 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
led successful mergers, acquisitions, and commercialization deals. These skills all will be helpful as we conduct our strategic review and continue
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
28 Apr 23
Additional proxy soliciting materials
4:03pm
and enhance shareholder value. Our Board and management team have the right skills and expertise to continue to unlock value for all shareholders. Each
DEF 14A
995jk6yyhbe7
10 May 21
Definitive proxy
4:06pm
PRE 14A
m0f dr25e
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.17
x4ab4k ehg35
24 Feb 21
Annual report
4:09pm
10-K
oj1irle1y2ne15n
24 Feb 21
Annual report
4:09pm
10-K
EX-10.16
hr090arm
24 Feb 21
Annual report
4:09pm
SUPPL
iehcpa x8
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
gpb16ukj kkzz
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
8am07mdorfdhia6ixzr9
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
4byu0lxl
29 May 20
Registration of securities (Canada)
4:07pm
6-K
EX-99.3
kyfo znxq9
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
40-F
EX-99.1
x5f1pdm7t
5 Mar 20
Annual report (Canada)
4:06pm